ZURICH—Roche’s newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of coronavirus, Roche said on Friday.
Governments around the world are urgently scouring databases for recent cases of COVID-19 infections, screening travelers, and decoding the viral genomes of the new variant as they try to measure how far it has spread.
